Free Trial
OTCMKTS:RADLY

Raia Drogasil Q2 2026 Earnings Results & Report

Raia Drogasil logo
$2.60 +0.03 (+1.21%)
As of 11/13/2026 03:26 PM Eastern

Raia Drogasil met analyst earnings expectations and missed on revenue in its Q2 2026 results, released August 4, 2026. The company reported EPS of $0.05 versus the $0.05 consensus estimate, while revenue of $2.17 billion fell short of the $2.32 billion estimate by $148.75 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Raia Drogasil EPS Results

Actual EPS
$0.05
Consensus EPS
$0.05
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Raia Drogasil Revenue Results

Actual Revenue
$2.17 billion
Expected Revenue
$2.32 billion
Beat/Miss
Missed by -$148.75 million
YoY Revenue Growth
N/A

Conference Call Resources

Raia Drogasil Q2 2026 Earnings FAQ

Raia Drogasil (OTCMKTS:RADLY) reported earnings of $0.05 per share for Q2 2026, matching the consensus estimate of $0.05. The report was announced on Tuesday, August 4, 2026.

Raia Drogasil reported revenue of $2.17 billion for Q2 2026, against a consensus estimate of $2.32 billion.

Raia Drogasil Earnings Headlines

You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
RADLY - Raia Drogasil S.A.
Raia Drogasil SA ADR RADLY
See More Raia Drogasil Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Raia Drogasil? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Raia Drogasil and other key companies, straight to your email.

About Raia Drogasil

Raia Drogasil (OTCMKTS:RADLY), now known as RD Saúde, is a Brazilian health and pharmacy retail company formed in 2011 through the merger of Droga Raia and Drogasil. It operates pharmacy stores under the Raia and Drogasil brands.

The company sells prescription and over-the-counter medicines, personal care and beauty products, and other health and wellness goods. It serves customers across Brazil through its retail locations and digital channels, including online ordering and delivery.

In addition to pharmacy retail, RD Saúde provides health-related services through its stores and digital platforms. Its business combines the legacy operations of two long-established Brazilian pharmacy chains.

View Raia Drogasil Profile